Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation

BACKGROUND: There is limited information on treatment strategies and monitoring strategies for late antibody-mediated rejection (ABMR) after kidney transplantation. METHODS: In this observational and nonrandomized study, we compared 78 patients diagnosed with late ABMR (>3 months after transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Parajuli, Sandesh, Mandelbrot, Didier A., Muth, Brenda, Mohamed, Maha, Garg, Neetika, Aziz, Fahad, Redfield, Robert R., Zhong, Weixiong, Astor, Brad C., Djamali, Arjang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828696/
https://www.ncbi.nlm.nih.gov/pubmed/29536028
http://dx.doi.org/10.1097/TXD.0000000000000746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828696/
https://www.ncbi.nlm.nih.gov/pubmed/29536028
http://dx.doi.org/10.1097/TXD.0000000000000746

Ejemplares similares